Related Experiment Video
Updated: Apr 25, 2026

Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype
Published on: June 17, 2022
Cell crowding induces interferon regulatory factor 9, which confers resistance to chemotherapeutic drugs
Iryna Kolosenko1, Mårten Fryknäs, Sofi Forsberg
1Department of Oncology-Pathology, Cancer Center Karolinska, Karolinska Institutet, 17176, Stockholm, Sweden.
Abstract:
The mechanism of multicellular drug resistance, defined as the reduced efficacy of chemotherapeutic drugs in solid tumors is incompletely understood. Here we report that colon carcinoma cells cultured as 3D microtissues (spheroids) display dramatic increases in the expression of a subset of type I interferon-(IFN)-stimulated genes (ISGs). A similar gene signature was associated previously with resistance to radiation and chemotherapy, prompting us to examine the underlying biological mechanisms. Analysis of spheroids formed by different tumor cell lines and studies using knock-down of gene expression showed that cell crowding leads to the induction of IFN regulatory factor-9 (IRF9) which together with STAT2 and independently of IFNs, is necessary for ISG upregulation. Increased expression of IRF9 alone was sufficient to induce the ISG subset in monolayer cells and to confer increased resistance to clinically used cytotoxic drugs. Our data reveal a novel mechanism of regulation of a subset of ISGs, leading to drug resistance in solid tumors.
Insights
Cell crowding in solid tumors upregulates interferon regulatory factor-9 (IRF9), driving drug resistance by increasing interferon-stimulated genes (ISGs). This reveals a new mechanism for overcoming chemotherapy resistance.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Multicellular drug resistance in solid tumors reduces chemotherapy efficacy.
- The precise mechanisms underlying this phenomenon remain incompletely understood.
Purpose of the Study:
- To investigate the biological mechanisms driving drug resistance in solid tumors.
- To identify key molecular players involved in multicellular drug resistance.
Main Methods:
- Culturing colon carcinoma cells as 3D microtissues (spheroids) to mimic solid tumors.
- Analyzing gene expression changes, specifically interferon-stimulated genes (ISGs).
- Utilizing gene knock-down studies and examining the role of Interferon Regulatory Factor-9 (IRF9).
Main Results:
- 3D spheroids exhibited significantly increased expression of a subset of ISGs.
- Cell crowding induced Interferon Regulatory Factor-9 (IRF9) expression, which, with STAT2 and independent of interferons (IFNs), upregulated ISGs.
- Elevated IRF9 expression alone conferred drug resistance in monolayer cells.
Conclusions:
- A novel mechanism for ISG regulation has been identified, contributing to drug resistance in solid tumors.
- IRF9 is a key mediator of ISG upregulation and subsequent chemoresistance in a cell-crowding context.
Related Concept Videos
Treatment Resistant Cancers
Inhibitors of Viral Protein Synthesis
Regulation of Hematopoietic Stem Cells
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Mechanisms of Retrovirus-induced Cancers

